Manuel Hidalgo Medina, MD, PhD

home / authors / manuel-hidalgo-medina-md-phd

Articles

Dr. Hidalgo Medina on Promising Research in Pancreatic Cancer

Dr. Hidalgo Medina on Promising Research in Pancreatic Cancer

Manuel Hidalgo Medina, MD, PhD
May 19th 2020

Manuel Hidalgo Medina, MD, PhD, discusses some of the exciting pancreatic cancer research presented at the 2020 ACCR Virtual Annual Meeting I.

Read More

Dr. Hidalgo Medina on the Rationale for Using Patient-Derived Organoids in Pancreatic Cancer

Dr. Hidalgo Medina on the Rationale for Using Patient-Derived Organoids in Pancreatic Cancer

Manuel Hidalgo Medina, MD, PhD
May 2nd 2020

Manuel Hidalgo Medina, MD, PhD, chief, Division of Hematology and Medical Oncology, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses that rationale for using patient-derived organoids (PDOs) in pancreatic cancer.

Read More

Dr. Hidalgo Medina on MSI and Germline Testing in Pancreatic Cancer

Dr. Hidalgo Medina on MSI and Germline Testing in Pancreatic Cancer

Manuel Hidalgo Medina, MD, PhD
December 17th 2019

Manuel Hidalgo Medina, MD, PhD, discusses microsatellite instability and germline testing patients with pancreatic cancer.

Read More

Dr. Hidalgo Medina on Treatment Considerations in Pancreatic Cancer

Dr. Hidalgo Medina on Treatment Considerations in Pancreatic Cancer

Manuel Hidalgo Medina, MD, PhD
December 5th 2019

Manuel Hidalgo Medina, MD, PhD, discusses treatment considerations in pancreatic cancer.

Read More

Dr. Hidalgo Medina on Neoadjuvant Therapy in Pancreatic Cancer

Dr. Hidalgo Medina on Neoadjuvant Therapy in Pancreatic Cancer

Manuel Hidalgo Medina, MD, PhD
November 16th 2019

Manuel Hidalgo Medina, MD, PhD, discusses the emergence of neoadjuvant chemotherapy and radiation in pancreatic cancer.

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data